IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0004824.html
   My bibliography  Save this article

Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-Analysis

Author

Listed:
  • André Russowsky Brunoni
  • Mariana Lopes
  • Ted J Kaptchuk
  • Felipe Fregni

Abstract

Background: Although meta-analyses have shown that placebo responses are large in Major Depressive Disorder (MDD) trials; the placebo response of devices such as repetitive transcranial magnetic stimulation (rTMS) has not been systematically assessed. We proposed to assess placebo responses in two categories of MDD trials: pharmacological (antidepressant drugs) and non-pharmacological (device- rTMS) trials. Methodology/Principal Findings: We performed a systematic review and meta-analysis of the literature from April 2002 to April 2008, searching MEDLINE, Cochrane, Scielo and CRISP electronic databases and reference lists from retrieved studies and conference abstracts. We used the keywords placebo and depression and escitalopram for pharmacological studies; and transcranial magnetic stimulation and depression and sham for non-pharmacological studies. All randomized, double-blinded, placebo-controlled, parallel articles on major depressive disorder were included. Forty-one studies met our inclusion criteria - 29 in the rTMS arm and 12 in the escitalopram arm. We extracted the mean and standard values of depression scores in the placebo group of each study. Then, we calculated the pooled effect size for escitalopram and rTMS arm separately, using Cohen's d as the measure of effect size. We found that placebo response are large for both escitalopram (Cohen's d - random-effects model - 1.48; 95%C.I. 1.26 to 1.6) and rTMS studies (0.82; 95%C.I. 0.63 to 1). Exploratory analyses show that sham response is associated with refractoriness and with the use of rTMS as an add-on therapy, but not with age, gender and sham method utilized. Conclusions/Significance: We confirmed that placebo response in MDD is large regardless of the intervention and is associated with depression refractoriness and treatment combination (add-on rTMS studies). The magnitude of the placebo response seems to be related with study population and study design rather than the intervention itself.

Suggested Citation

  • André Russowsky Brunoni & Mariana Lopes & Ted J Kaptchuk & Felipe Fregni, 2009. "Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-Analysis," PLOS ONE, Public Library of Science, vol. 4(3), pages 1-10, March.
    • Handle: RePEc:plo:pone00:0004824
    DOI: 10.1371/journal.pone.0004824
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004824
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0004824&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0004824?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Irving Kirsch & Brett J Deacon & Tania B Huedo-Medina & Alan Scoboria & Thomas J Moore & Blair T Johnson, 2008. "Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration," PLOS Medicine, Public Library of Science, vol. 5(2), pages 1-9, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Weisz, George & Knaapen, Loes, 2009. "Diagnosing and treating premenstrual syndrome in five western nations," Social Science & Medicine, Elsevier, vol. 68(8), pages 1498-1505, April.
    2. Felicity Thomas & Lorraine Hansford & Joseph Ford & Katrina Wyatt & Rosemarie McCabe & Richard Byng, 2018. "Moral narratives and mental health: rethinking understandings of distress and healthcare support in contexts of austerity and welfare reform," Palgrave Communications, Palgrave Macmillan, vol. 4(1), pages 1-8, December.
    3. Klaus Munkholm & Stephanie Winkelbeiner & Philipp Homan, 2020. "Individual response to antidepressants for depression in adults-a meta-analysis and simulation study," PLOS ONE, Public Library of Science, vol. 15(8), pages 1-16, August.
    4. Ad. J. W. van de Gevel & Charles N. Noussair, 2013. "The Nexus between Artificial Intelligence and Economics," SpringerBriefs in Economics, Springer, edition 127, number 978-3-642-33648-5, September.
    5. Bütikofer, Aline & Cronin, Christopher J. & Skira, Meghan M., 2020. "Employment effects of healthcare policy: Evidence from the 2007 FDA black box warning on antidepressants," Journal of Health Economics, Elsevier, vol. 73(C).
    6. William Hollingworth & Christopher G. Fawsitt & Padraig Dixon & Larisa Duffy & Ricardo Araya & Tim J. Peters & Howard Thom & Nicky J. Welton & Nicola Wiles & Glyn Lewis, 2020. "Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT," PharmacoEconomics - Open, Springer, vol. 4(3), pages 427-438, September.
    7. Bishop, Felicity L. & Jacobson, Eric E. & Shaw, Jessica R. & Kaptchuk, Ted J., 2012. "Scientific tools, fake treatments, or triggers for psychological healing: How clinical trial participants conceptualise placebos," Social Science & Medicine, Elsevier, vol. 74(5), pages 767-774.
    8. Garret Christensen & Edward Miguel, 2018. "Transparency, Reproducibility, and the Credibility of Economics Research," Journal of Economic Literature, American Economic Association, vol. 56(3), pages 920-980, September.
    9. Nagel, Mats, 2020. "Changing perspectives: Towards detailed phenotyping in genetics," Thesis Commons a4nz2, Center for Open Science.
    10. Liebert, Rachel & Gavey, Nicola, 2009. ""There are always two sides to these things": Managing the dilemma of serious adverse effects from SSRIs," Social Science & Medicine, Elsevier, vol. 68(10), pages 1882-1891, May.
    11. Janus Christian Jakobsen & Jane Lindschou Hansen & Ole Jakob Storebø & Erik Simonsen & Christian Gluud, 2011. "The Effects of Cognitive Therapy Versus ‘Treatment as Usual’ in Patients with Major Depressive Disorder," PLOS ONE, Public Library of Science, vol. 6(8), pages 1-11, August.
    12. Busfield, Joan, 2015. "Assessing the overuse of medicines," Social Science & Medicine, Elsevier, vol. 131(C), pages 199-206.
    13. Lennon, Carter A. & Huedo-Medina, Tania B. & Gerwien, Daniel P. & Johnson, Blair T., 2012. "A role for depression in sexual risk reduction for women? A meta-analysis of HIV prevention trials with depression outcomes," Social Science & Medicine, Elsevier, vol. 75(4), pages 688-698.
    14. Malcom Hopwood, 2020. "The Shared Decision-Making Process in the Pharmacological Management of Depression," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 13(1), pages 23-30, February.
    15. Light, Donald W. & Lexchin, Joel R., 2021. "Pharmaceuticals as a market for “lemons”: Theory and practice," Social Science & Medicine, Elsevier, vol. 268(C).
    16. Nagel, Mats, 2020. "Changing perspectives: Towards detailed phenotyping in genetics," Thesis Commons a4nz2_v1, Center for Open Science.
    17. Janus Christian Jakobsen & Jane Lindschou Hansen & Erik Simonsen & Christian Gluud, 2011. "The Effect of Interpersonal Psychotherapy and other Psychodynamic Therapies versus ‘Treatment as Usual’ in Patients with Major Depressive Disorder," PLOS ONE, Public Library of Science, vol. 6(4), pages 1-9, April.
    18. Michael A Sugarman & Amy M Loree & Boris B Baltes & Emily R Grekin & Irving Kirsch, 2014. "The Efficacy of Paroxetine and Placebo in Treating Anxiety and Depression: A Meta-Analysis of Change on the Hamilton Rating Scales," PLOS ONE, Public Library of Science, vol. 9(8), pages 1-15, August.
    19. Lijuan Guo & Zhaowei Kong & Yanjie Zhang, 2019. "Qigong-Based Therapy for Treating Adults with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials," IJERPH, MDPI, vol. 16(5), pages 1-11, March.
    20. Giuliano Masiero & Fabrizio Mazzonna & Sandro Steinbach & Olaf Verbeek, 2019. "The effect of local growth in antidepressant consumption on mental health outcomes," IdEP Economic Papers 1902, USI Università della Svizzera italiana.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0004824. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.